Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prazosin for Stress Reactivity in Alcohol Use Disorder
NCT02966340Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prazosin in alcohol use disorder (AUD), sponsored by University of Wisconsin–Madison. Primary endpoint: Startle Potentiation During NPU Task at 7 days. Started Nov 2016; status: completed.
02
Drugs
prazosin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02966340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02966340.